NCIC CTG IND.196: PHASE I STUDY OF FORETINIB (GSK1363089) AND ERLOTINIB IN PATIENTS WITH ADVANCED PRETREATED NSCLC
Conferences
-
- Overview
-
- Research
-
- Additional Document Info
-
- View All
-
Overview
status
publication date
has subject area
published in
Research
keywords
-
Erlotinib
-
Life Sciences & Biomedicine
-
MET inhibitor
-
NSCLC
-
Oncology
-
Respiratory System
-
Science & Technology
-
phase I
Additional Document Info
start page
end page
volume
issue